Midgard Science

FyoniBio

Berlin, Germanyfyonibio.comFrom their website, Nov 2026

  • GMP
  • ISO 9001

Work here? Claim this listing

About

FyoniBio develops biologics and provides bioanalytical support for clinical trials and biologic characterization. It works with biopharmaceutical programs from discovery and cell line development through process development, analytics, and clinical bioanalysis. The company is based in Berlin, Germany.

Services

  • Cell Line Development

    Develops mammalian cell lines for biotherapeutics using CHO and human platforms, including tailored expression systems for complex molecules.

    Cell line development

  • CHOFlow® Cell Line Development

    Provides a glycoengineered CHO platform for producing afucosylated monoclonal antibodies and other glycoproteins with enhanced ADCC.

    Cell line development

  • CHOnamite® Cell Line Development

    Offers a CHO-based platform for high-yield production of biotherapeutics and classical mAb glycosylation.

    Cell line development

  • GlycoExpress® Cell Line Development

    Provides a human expression platform for proteins that require authentic human post-translational modifications and complex glycosylation.

    Cell line development

  • Process Development

    Supports upstream and downstream process development and optimization to prepare biologics for scalable manufacturing.

  • Analytical Services and Bioassays

    Performs biochemical analytics and bioassay development to characterize biologics across development stages.

  • Mass Spectrometry Analytics

    Uses mass spectrometry for characterization of critical quality attributes such as glycosylation, integrity, and PTMs.

  • Clinical Bioanalysis

    Develops and runs bioanalytical methods for PK, PD, and immunogenicity studies in clinical samples.

    ADME, DMPK & toxicology

3 more services
  • Functional and Potency Bioassays
  • Bioanalytical Support for Clinical Trials
  • Bioanalytical Characterization
Turnaround
Typically respond within 24 hours
What to send
  • Blood-derived matrices like serum and plasma
  • Tissue-based materials

Capabilities

Assays and studies
  • Bioanalysis
  • Process development
  • Antibodies
  • Immunogenicity
  • Oligonucleotides
  • CHO
18 more
  • PK/PD
  • ADCs
  • LC-MS/MS
  • Cell-based assays
  • PK assays
  • PD assays
  • Immunogenicity assays
  • ADA assays
  • Neutralizing antibody assays
  • Biomarker analysis
  • SNP analysis
  • Immune cell profiling
  • Functional assays
  • Ligand binding assays
  • Hybrid LC-MS/MS methods
  • SEC
  • WCX/WAX
  • RPC
Scale and capacity
  • Analysis capacity of up to 10,000 samples per year
  • High yields > 12 g/L for some mAbs
  • High yields > 5 g/L in standard fed-batch processes
  • Stability over > 70 population doublings
Therapeutic areas
Immuno-oncology

Instruments and platforms

  • LC-MS
  • Octet BLI
  • DRX2
  • AlphaScreen
  • TÜV Rheinland

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • ADC
  • Oligonucleotide
  • Recombinant protein
  • Biosimilar
Species and models
  • CHO-K1
  • CHO-GS-KO
  • CHO-DG44
  • Human cell lines
  • FcγRIIIa
  • NK cells

Certifications

As the company states them, with the certificate or registry record where there is one.

  • ISO 9001:2015Self-reported

    Scope: quality management systems

  • GMPSelf-reported

Details

Type
CRDMO
Founded
2022
Based in
Berlin, Germany
Serves
Global
General enquiry
contact@fyonibio.com on their site

Similar labs